Skip to content

Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Postoperative Inflammation in Cataract Surgery

Efficacy of Antibiotic Steroid Combination Compared With Individual Administration in Prevention of Postoperative Inflammation in Patients Having Cataract Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00331084
Enrollment
132
Registered
2006-05-29
Start date
2006-04-30
Completion date
2007-03-31
Last updated
2009-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation Following Cataract Surgery

Keywords

prevention of post inflammation in cataract surgery

Brief summary

efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having cataract surgery

Detailed description

Study of 15 +-1 day, double-masked, randomized, two arms, parallel groups to confirm the efficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having cataract surgery

Interventions

1 gtt, 4x/day, 15 days

DRUGmoxifloxacin / dexamethasone

1 gtt 4x/day, 15 days

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients having cataract surgery

Exclusion criteria

* Uncontrolled glaucoma or intraocular hypertension; * Use of any ocular anti-infectious drugs or any topical or systemic ocular NSAIDs during the study but study drugs; * A history of chronic or recurrent ocular inflammatory disease; * Uncontrolled diabetes mellitus and diabetic retinopathy ; * Patients with sight in a single eye; * Iris atrophy in the eye to be operated; * Pregnant or lactating women, or women of childbearing potential who are not using proper birth-control methods; * Known or suspected allergy or hypersensitivity to any component of study medication; * A history or any other evidence of severe systemic disease

Design outcomes

Primary

MeasureTime frame
day 15 evaluation of anterior chamber15 days pos-op

Secondary

MeasureTime frame
day 15 evaluation of ocular pain, physician´s follow-up impression of inflammatory reaction score15 days pos-op

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026